A combination of $4.35 million in public and private funding is boosting the Quebec Pain Research Network (QPRN) by enhancing its research and education programs. The four-year funding package is being provided by the Fonds de la recherche en santé du Québec (FRSQ) ($2 million), Pfizer Canada ($1.